139 related articles for article (PubMed ID: 15124704)
1. The U.S. trials in adult acute lymphoblastic leukemia.
Larson RA
Ann Hematol; 2004; 83 Suppl 1():S127-8. PubMed ID: 15124704
[No Abstract] [Full Text] [Related]
2. Curability of cancer in childhood and adolescence: acute lymphoblastic leukemia.
Mann G; Gadner H
Wien Klin Wochenschr; 2002 Feb; 114(4):141-2. PubMed ID: 12060979
[No Abstract] [Full Text] [Related]
3. Blinatumomab: a novel agent to treat minimal residual disease in patients with acute lymphoblastic leukemia.
Advani AS
Clin Adv Hematol Oncol; 2011 Oct; 9(10):776-7. PubMed ID: 22252580
[No Abstract] [Full Text] [Related]
4. Acute lymphoblastic leukemia in adolescents and young adults in Finland.
Usvasalo A; Räty R; Knuutila S; Vettenranta K; Harila-Saari A; Jantunen E; Kauppila M; Koistinen P; Parto K; Riikonen P; Salmi TT; Silvennoinen R; Elonen E; Saarinen-Pihkala UM
Haematologica; 2008 Aug; 93(8):1161-8. PubMed ID: 18556413
[TBL] [Abstract][Full Text] [Related]
5. Importance of minimal residual disease testing during the second year of disease: still no answer?
Aricò M; Conter V; Valsecchi MG; Masera G
J Clin Oncol; 2003 Dec; 21(23):4463-4; author reply 4464-5. PubMed ID: 14645441
[No Abstract] [Full Text] [Related]
6. Oncology. In their prime, and dying of cancer.
Couzin J
Science; 2007 Aug; 317(5842):1160-2. PubMed ID: 17761859
[No Abstract] [Full Text] [Related]
7. Survival in France after childhood acute leukaemia and non-Hodgkin's lymphoma (1990-2000).
Goubin A; Auclerc MF; Auvrignon A; Patte C; Bergeron C; Hémon D; Clavel J
Eur J Cancer; 2006 Mar; 42(4):534-41. PubMed ID: 16412629
[TBL] [Abstract][Full Text] [Related]
8. IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report.
Martinelli G; Iacobucci I; Storlazzi CT; Vignetti M; Paoloni F; Cilloni D; Soverini S; Vitale A; Chiaretti S; Cimino G; Papayannidis C; Paolini S; Elia L; Fazi P; Meloni G; Amadori S; Saglio G; Pane F; Baccarani M; Foà R
J Clin Oncol; 2009 Nov; 27(31):5202-7. PubMed ID: 19770381
[TBL] [Abstract][Full Text] [Related]
9. Minimal residual disease (MRD) monitoring using rearrangement of T-cell receptor and immunoglobulin H gene in the treatment of adult acute lymphoblastic leukemia patients.
Toubai T; Tanaka J; Ota S; Fukuhara T; Hashino S; Kondo T; Kasai M; Kakinoki Y; Masauzi N; Morioka M; Kawamura T; Iwasaki H; Asaka M; Imamura M
Am J Hematol; 2005 Nov; 80(3):181-7. PubMed ID: 16247752
[TBL] [Abstract][Full Text] [Related]
10. [New therapeutic strategy for Philadelphia chromosome-positive acute lymphoblastic leukemia].
Usui N
Rinsho Ketsueki; 2006 Apr; 47(4):294-302. PubMed ID: 16715964
[No Abstract] [Full Text] [Related]
11. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
[TBL] [Abstract][Full Text] [Related]
12. Changes in antithrombin and fibrinogen levels during induction chemotherapy with L-asparaginase in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma. Use of supportive coagulation therapy and clinical outcome: the CAPELAL study.
Hunault-Berger M; Chevallier P; Delain M; Bulabois CE; Bologna S; Bernard M; Lafon I; Cornillon J; Maakaroun A; Tizon A; Padrazzi B; Ifrah N; Gruel Y;
Haematologica; 2008 Oct; 93(10):1488-94. PubMed ID: 18728028
[TBL] [Abstract][Full Text] [Related]
13. Molecular detection of minimal residual disease is associated with early relapse in adult acute lymphoblastic leukemia.
Specchia G; Liso A; Pannunzio A; Albano F; Mestice A; Pastore D; Liso V
Haematologica; 2004 Oct; 89(10):1271-3. PubMed ID: 15477219
[TBL] [Abstract][Full Text] [Related]
14. Aggressive chemotherapy of ALL in elderly patients.
Hoelzer D
Hematol Oncol; 1993; 11 Suppl 1():12-4. PubMed ID: 8486336
[No Abstract] [Full Text] [Related]
15. [Acute lymphoblastic leukemia (ALL)].
Imai K; Akiyama H
Gan To Kagaku Ryoho; 2007 Dec; 34(13):2180-4. PubMed ID: 18079617
[TBL] [Abstract][Full Text] [Related]
16. St Jude researchers use DNA chips to determine how leukemia cells responds to different drug treatments.
Pharmacogenomics; 2003 May; 4(3):244. PubMed ID: 12774778
[No Abstract] [Full Text] [Related]
17. Hyperglycemia during induction of acute lymphocytic leukemia.
Wilmott RW
J Pediatr; 2009 Jul; 155(1):A2. PubMed ID: 19559280
[No Abstract] [Full Text] [Related]
18. Quest for effective agents to combat T-cell acute lymphoblastic leukemia.
Pui CH
Eur J Cancer; 2005 Jun; 41(9):1243-5. PubMed ID: 15939259
[No Abstract] [Full Text] [Related]
19. Nelarabine.
Gandhi V; Keating MJ; Bate G; Kirkpatrick P
Nat Rev Drug Discov; 2006 Jan; 5(1):17-8. PubMed ID: 16485343
[No Abstract] [Full Text] [Related]
20. Pediatric regimens for adult acute lymphoblastic leukemia.
Stock W
Clin Adv Hematol Oncol; 2009 Apr; 7(4):244-6. PubMed ID: 19521325
[No Abstract] [Full Text] [Related]
[Next] [New Search]